Loading stock data…
RYAM
$9.31-0.18 (-1.90%)
After Hours$9.31+0.00 (+0.00%)· Last close May 1
Rayonier Advanced Materials Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Rayonier Advanced Materials Inc. in the Basic Materials sector is trading at $9.33. The stock is currently 21% below its 52-week high of $11.85, remaining 27.5% above its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why RYAM maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 42) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$9.31
Potential Upside
5%
Whystock Fair Value$9.78
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus2 analysts
Buy
Mean target$14.50+55.7%
Range$14.00 – $15.00
Fundamentals
Rayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Europe, Japan, rest of Asia, Canada, Latin America, and internationally. It operates through Cellulose Specialties, Biomaterials, Cellul...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$638.89M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.03
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-140.25%
Volume
Today's trading volume
518,205
Recent News
IP Misses Q1 Earnings Estimates, Lowers 2026 EBITDA View on Higher Costs
International Paper misses Q1 estimates as costs climb, cuts 2026 EBITDA outlook and flags macro pressures despite stronger cash flow and portfolio moves.
Smurfit Westrock Falls Short of Earnings & Revenue Estimates in Q1
SW misses Q1 earnings and revenue estimates as profits tumble, with weather impacts and weak North America volumes weighing on results.
Smurfit Westrock (SW) Q1 Earnings and Revenues Lag Estimates
Smurfit Westrock (SW) delivered earnings and revenue surprises of -7.49% and -0.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
How The Rayonier Advanced Materials (RYAM) Story Is Shifting With Value Over Volume And Pricing
Analysts are centering their latest update on Rayonier Advanced Materials around a US$14 price target, alongside an unchanged US$14.50 fair value estimate. They link this target to the company’s value over volume focus and pricing efforts, while still flagging execution and market risks that could affect how the story develops. As you read on, you will see how this evolving analyst narrative might shape the way you think about Rayonier Advanced Materials from here. Analyst Price Targets don't...
How Rayonier Advanced Materials (RYAM) Is Reframing Its Value Story With New Analyst Targets
Rayonier Advanced Materials is back on investor radars after analysts lifted their price target fair value from $11.50 to $14.50, about 26% higher than the prior level. Supporters of the move point to recent results and market reaction, arguing that clearer execution on pricing, mix, and a value over volume focus helps justify the higher target. Read on to see how to track this evolving analyst narrative and what it may mean for your own research on the stock. Stay updated as the Fair Value...